Search research articles
Contact Us
Filters
Showing results (161-170 of 456) with videos related to
Page
of 46
Sort By:
Frontiers in Medicine
|
June 2, 2023
Corrigendum: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021
Li-Teh Liu, Jih-Jin Tsai, Ko Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 3, 2017
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 16, 2006
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels
Ming-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
July 16, 2011
Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups
Jeng-Fu Yang, Ya-Yun Lin, Meng-Hsuan Hsieh, et al.
The Kaohsiung Journal of Medical Sciences
|
July 17, 2009
Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients
Jeng-Fu Yang, Ya-Yun Lin, Jee-Fu Huang, et al.
Plos One
|
May 5, 2017
Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
Jee-Fu Huang, Ming-Lun Yeh, Chung-Feng Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 1, 2017
Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
Ming-Lung Yu, Yao-Li Chen, Chung-Feng Huang, et al.
Alimentary Pharmacology & Therapeutics
|
December 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2011
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection
Jee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu, et al.
Antiviral Research
|
November 26, 2009
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 46
Search research articles
Search
Showing results (161-170 of 456) with videos related to
Sort By:
Page
of 46
Frontiers in Medicine
|
June 2, 2023
Corrigendum: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021
Li-Teh Liu, Jih-Jin Tsai, Ko Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 3, 2017
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 16, 2006
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels
Ming-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
July 16, 2011
Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups
Jeng-Fu Yang, Ya-Yun Lin, Meng-Hsuan Hsieh, et al.
The Kaohsiung Journal of Medical Sciences
|
July 17, 2009
Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients
Jeng-Fu Yang, Ya-Yun Lin, Jee-Fu Huang, et al.
Plos One
|
May 5, 2017
Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
Jee-Fu Huang, Ming-Lun Yeh, Chung-Feng Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 1, 2017
Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
Ming-Lung Yu, Yao-Li Chen, Chung-Feng Huang, et al.
Alimentary Pharmacology & Therapeutics
|
December 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2011
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection
Jee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu, et al.
Antiviral Research
|
November 26, 2009
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 46